Ross, D M
Article History
Received: 20 October 2016
Accepted: 31 October 2016
First Online: 9 December 2016
Competing interests
: DMR reports clinical trial or research funding from Celgene, Gilead, and Novartis to his institution. He has received honoraria from Novartis.